Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Spendlove

Anesthesiology Spokane Valley, WA Doctor of Osteopathy

NPI 1417240961 CMS profile 1378971

1414 N Vercler Rd Ste 5, Spokane Valley, WA 99216

Open in the dashboard

General payments

$32,218

551 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$300 paid to institutions, not to them · program year 2020

Through program year 2025, Scott Spendlove of Spokane Valley, WA is reported in the CMS Open Payments database as having received $32,218 across 551 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $300 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,725 26
2024 General $845 17
2023 General $4,760 43
2022 General $1,810 40
2021 General $10,909 90
2020 General $3,587 92
2019 General $8,582 243

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Spendlove
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Scott Spendlove were reported at $1,725. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Scott Spendlove Anesthesiology median Middle half National median
2019 $8,582 $72 $23–$151 $163
2020 $3,587 $36 $17–$120 $114
2021 $10,909 $49 $21–$135 $132
2022 $1,810 $52 $22–$144 $149
2023 $4,760 $53 $23–$143 $160
2024 $845 $55 $25–$150 $164
2025 $1,725 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $13,802 106 payments
  2. Nevro Corp. $5,773 112 payments
  3. Nalu Medical, Inc. $2,531 24 payments
  4. Abbott Laboratories $2,424 38 payments
  5. Medtronic USA, Inc. $1,916 31 payments
  6. Saluda Medical Americas, Inc. $1,251 8 payments
  7. Daiichi Sankyo Inc. $923 94 payments
  8. Medtronic, Inc. $797 12 payments
  9. Flowonix Medical Incorporated $364 1 payment
  10. SI-BONE, Inc. $312 5 payments
  11. Other $2,127 120 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $18,789 533 payments
  2. Travel and Lodging $7,629 17 payments
  3. Consulting Fee $5,800 1 payment
Products named General payments · program years 2019–2025
  1. WAVEWRITER ALPHA $5,854 3 payments
  2. Senza Spinal Cord Stimulation System $3,800 72 payments
  3. Nalu Neurostimulation System $2,531 24 payments
  4. GENERAL PAIN MANAGEMENT $2,496 13 payments
  5. Proclaim Family of SCS IPGs $2,213 30 payments
  6. Omnia $1,380 28 payments
  7. SYNCHROMED $1,252 17 payments
  8. Evoke $1,251 8 payments
  9. SPECTRA WAVEWRITER $1,150 20 payments
  10. Morphabond ER $901 91 payments
  11. Other $8,817 318 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$33,470

Of which drugs: $45

Medicare patients

119

Average age 73

Services billed

324

65 women, 54 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 70%
Diabetes 36%
Depression 34%
Chronic kidney disease 33%
Ischemic heart disease 29%
Heart failure 24%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

551 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record